Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans

(2014) Iván Plaza-Menacho et al.   MOLECULAR CELL

Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations

(2014) Thereasa A. Rich et al.   THYROID

Disease variants in genomes of 44 centenarians

(2014) Yun Freudenberg-Hua et al.   Molecular Genetics & Genomic Medicine

Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes

(2013) Mariola Pęczkowska et al.   CLINICAL ENDOCRINOLOGY

Thyroid cancer and co-occurring RET mutations in Hirschsprung disease

(2013) Valtter B Virtanen et al.   ENDOCRINE-RELATED CANCER

Multiple Functional Effects of RET Kinase Domain Sequence Variants in Hirschsprung Disease

(2012) Brandy D. Hyndman et al.   HUMAN MUTATION

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer

(2011) B Cosci et al.   ENDOCRINE-RELATED CANCER

RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system

(2011) Felix Rückert et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Mendelian genetics of rare-and not so rare-cancers

(2010) Charis Eng   Annals of the New York Academy of Sciences

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

(2010) Yun Li et al.   GENETIC EPIDEMIOLOGY

High Penetrance of Pheochromocytoma Associated with the Novel C634Y/Y791F Double Germline Mutation in theRETProtooncogene

(2010) Rodrigo A. Toledo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

(2010) Samuel A. Wells et al.   JOURNAL OF CLINICAL ONCOLOGY

DOG 1.0: illustrator of protein domain structures

(2009) Jian Ren et al.   CELL RESEARCH

New Mutations in the RET Protooncogene-L881V – Associated with Medullary Thyroid Carcinoma and -R770Q – in a Patient with Mixed Medullar/Follicular Thyroid Tumour

(2009) K. Frank-Raue et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Multiple endocrine neoplasia type 2RETprotooncogene database: Repository of MEN2-associatedRETsequence variation and reference for genotype/phenotype correlations

(2009) Rebecca L. Margraf et al.   HUMAN MUTATION

Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome

(2009) Zoran Erlic et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8

(2009) Elmar Krieger et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

(2009) Richard T. Kloos (Chair) et al.   THYROID

Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791*

(2008) Karin Frank-Raue et al.   CLINICAL ENDOCRINOLOGY

Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma.

(2008) Mario Colombo-Benkmann et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY